Unknown

Dataset Information

0

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling.


ABSTRACT: BACKGROUND:Lingguizhugan decoction (LGZG), an ancient Chinese herbal formula, has been used to treat cardiovascular diseases in eastern Asia. We investigated whether LGZG has protective activity and the mechanism underlying its effect in an animal model of heart failure (HF). METHODS:A rat model of HF was established by administering eight intraperitoneal injections of doxorubicin (DOX) (cumulative dose of 16?mg/kg) over a 4-week period. Subsequently, LGZG at 5, 10, and 15?mL/kg/d was administered to the rats intragastrically once daily for 4?weeks. The body weight, heart weight index (HWI), heart weight/tibia length ratio (HW/TL), and serum BNP level were investigated to assess the effect of LGZG on HF. Echocardiography was performed to investigate cardiac function, and H&E staining to visualize myocardial morphology. Myocardial ultrastructure and T-tubule-sarcoplasmic reticulum (TT-SR) junctions were observed by transmission electron microscopy. The JP-2 protein level was determined by Western blotting. The mRNA level of CACNA1S and RyR2 and the microRNA-24 (miR-24) level were assayed by quantitative RT-PCR. RESULTS:Four weeks after DOX treatment, rats developed cardiac damage and exhibited a significantly increased BNP level compared with the control rats (169.6?±?29.6?pg/mL versus 80.1?±?9.8?pg/mL, P?

SUBMITTER: Li X 

PROVIDER: S-EPMC6907350 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling.

Li Xueping X   Xu Guangmin G   Wei Shujun S   Zhang Baocheng B   Yao Huan H   Chen Yuchi Y   Liu Weiwei W   Wang Baojia B   Zhao Juan J   Gao Yongxiang Y  

BMC complementary and alternative medicine 20191211 1


<h4>Background</h4>Lingguizhugan decoction (LGZG), an ancient Chinese herbal formula, has been used to treat cardiovascular diseases in eastern Asia. We investigated whether LGZG has protective activity and the mechanism underlying its effect in an animal model of heart failure (HF).<h4>Methods</h4>A rat model of HF was established by administering eight intraperitoneal injections of doxorubicin (DOX) (cumulative dose of 16 mg/kg) over a 4-week period. Subsequently, LGZG at 5, 10, and 15 mL/kg/d  ...[more]

Similar Datasets

| S-EPMC9908757 | biostudies-literature
| S-EPMC9117701 | biostudies-literature
| S-EPMC5831972 | biostudies-literature
| S-EPMC7397417 | biostudies-literature
| S-EPMC7375406 | biostudies-literature
| S-EPMC6356724 | biostudies-literature
2023-03-31 | GSE147834 | GEO
| S-EPMC5322393 | biostudies-literature
| S-EPMC5136544 | biostudies-literature
| S-EPMC8255388 | biostudies-literature